Health
Healthcare Industry Faces Legal Challenges
A U.S. judge rejected Eli Lilly's attempt to block Novo Nordisk from running a weight loss drug advertising campaign. The decision could have implications for future pharmaceutical marketing.
Coverage timeline — 1 article
STAT News
A U.S. judge rejected a bid to block Eli Lilly from running what Novo Nordisk claims is a “deceptive” advertising campaign about weight loss drugs
2026-10-27 13:25 UTC